Hyperthermic intraperitoneal chemotherapy

Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis
Martina Aida Angeles, François Quenet, Pierre Vieille, Laurence Gladieff, Jean Ruiz, Muriel Picard, Federico Migliorelli, Leonor Chaltiel, Carlos Martínez-Gómez, Alejandra Martinez, Gwénaël Ferron

International Journal of Gynecologic Cancer Feb 2019, 29 (2) 382-391; DOI: 10.1136/ijgc-2018-000099
Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma
Teresa P. Díaz-Montes, Farah El-Sharkawy, Sarah Lynam, Amy Harper, Michelle Sittig, Ryan MacDonald, Vadim Gushchin, Armando Sardi

International Journal of Gynecologic Cancer Jun 2018, 28 (6) 1130-1137; DOI: 10.1097/IGC.0000000000001289
Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al
Philipp Harter, Alexander Reuss, Jalid Sehouli, Luis Chiva, Andreas du Bois

International Journal of Gynecologic Cancer Feb 2017, 27 (2) 246-247; DOI: 10.1097/IGC.0000000000000864

Main menu